Disc Medicine, Inc. (IRON) is a publicly traded company in the Healthcare sector, operating within the Biotechnology industry. The company is headquartered in Watertown, MA, United States. The current CEO is John D. Quisel.
IRON has IPO date of 2020-08-12, 94 full-time employees, listed on the NASDAQ Global Market, a market capitalization of $2.69B.
Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.
